|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4,465.00 KRW | 0.00% |
|
-17.77% | -34.53% |
| 12-09 | GC Genome Study Identifies 'Confounders' Interfering with Cancer Signals to Improve Liquid Biopsy Accuracy | CI |
| 25-06-12 | GC Genome Shares Decline Nearly 3% After Strong Kosdaq Debut | MT |
Share class: GC Genome Corporation
| Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
|---|---|---|---|---|---|
| Stock A | 1 | 23,650,793 | 11,729,597 ( 49.59 %) | 0 | 49.59 % |
Major shareholders: GC Genome Corporation
| Name | Stocks | % | Valuation |
|---|---|---|---|
19.6
%
| 4,636,500 | 19.6 % | 19 M ₩ |
9.542
%
| 2,256,656 | 9.542 % | 9 M ₩ |
Ginnovation 1st Pvt Equity Investment Partnership
4.038
%
| 955,039 | 4.038 % | 4 M ₩ |
3.579
%
| 846,428 | 3.579 % | 3 M ₩ |
3.316
%
| 784,357 | 3.316 % | 3 M ₩ |
2.147
%
| 507,857 | 2.147 % | 2 M ₩ |
1.193
%
| 282,142 | 1.193 % | 1 M ₩ |
0.7158
%
| 169,285 | 0.7158 % | 676 241 ₩ |
0.6442
%
| 152,357 | 0.6442 % | 608 619 ₩ |
0.5845
%
| 138,250 | 0.5845 % | 552 266 ₩ |
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░ ░░░ | ░░░░% | ░░ |
░░░░░░░░░░░░░░░░░░░ | ░ ░░░ | ░░░░% | ░░ |
░░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░ ░░░ | ░░░░% | ░░ |
░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░ ░░░ | ░░░░% | ░░ |
░░░░░░░░░░░░░░░░░░░░░ | ░ ░░░ | ░░░░% | ░░ |
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░ ░░░ | ░░░░% | ░░ |
░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░ ░░░ | ░░░░% | ░░ |
░░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░ ░░░ | ░░░░% | ░░ |
Breakdown by shareholder type
| GC Biopharma Corp. | 19.6% |
| Individuals | 13.41% |
| GC Corp. | 9.54% |
| Others | 4.04% |
| GC Cell Corp. | 0.1% |
| GC Medical Science Corp. | 0.07% |
| Unknown | 53.24% |
Based on 1000 largest holdings
Geographical origin of shareholders
South Korea | 33.35% |
Individuals
| 13.41% |
Based on 1000 largest holdings
Employees
-
- Stock Market
- Stocks
- A340450 Stock
- Company GC Genome Corporation
- Share ownership
Select your edition
All financial news and data tailored to specific country editions
















